comparemela.com

Latest Breaking News On - Nasdaq iclr - Page 2 : comparemela.com

ICON Public (NASDAQ:ICLR) Given New $349 00 Price Target at TD Cowen

ICON Public (NASDAQ:ICLR – Get Free Report) had its price target lifted by stock analysts at TD Cowen from $343.00 to $349.00 in a research report issued to clients and investors on Friday, Benzinga reports. The brokerage currently has a “buy” rating on the medical research company’s stock. TD Cowen’s price objective points to a […]

ICON Public (NASDAQ:ICLR) Price Target Raised to $349 00 at TD Cowen

ICON Public (NASDAQ:ICLR – Get Free Report) had its price objective upped by equities researchers at TD Cowen from $343.00 to $349.00 in a note issued to investors on Friday, Benzinga reports. The firm currently has a “buy” rating on the medical research company’s stock. TD Cowen’s target price points to a potential upside of […]

ICON Public (NASDAQ:ICLR) Updates FY24 Earnings Guidance

ICON Public (NASDAQ:ICLR – Get Free Report) updated its FY24 earnings guidance on Wednesday. The company provided earnings per share guidance of $14.65-$15.15 for the period, compared to the consensus earnings per share estimate of $14.94. The company issued revenue guidance of $8.48-$8.72 billion, compared to the consensus revenue estimate of $8.64 billion. Wall Street […]

ICON Public (NASDAQ:ICLR) Releases FY24 Earnings Guidance

ICON Public (NASDAQ:ICLR – Get Free Report) issued an update on its FY24 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of $14.65-$15.15 for the period, compared to the consensus estimate of $14.94. The company issued revenue guidance of $8.48-$8.72 billion, compared to the consensus revenue estimate of $8.64 billion. […]

ICON Public Limited (NASDAQ:ICLR) Shares Acquired by Pinnacle Bancorp Inc

Pinnacle Bancorp Inc. boosted its holdings in ICON Public Limited (NASDAQ:ICLR – Free Report) by 110.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 105 shares of the medical research company’s stock after purchasing an additional 55 shares […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.